Inactive Instrument
Acusphere, Inc. Stock Other OTC
Stocks
US00511R8705
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06/11/13 | Acusphere Appoints William Ramage as Chief Development Officer | CI |
| 21/10/13 | Acusphere, Inc. has Changed its Ticker to ACUS from ACUSD | CI |
| Market Cap | 3.46M 2.99M 2.76M 2.58M 4.84M 329M 4.91M 32.56M 12.7M 160M 13M 12.73M 555M | P/E Ratio 2006 |
-1.06x | P/E Ratio 2007 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | -11.29M -9.75M -8.99M -8.41M -15.77M -1.07B -16.01M -106M -41.38M -522M -42.38M -41.48M -1.81B | EV / Sales 2006 |
9,811,030x | EV / Sales 2007 | 5,744,305x |
| Free-Float |
100% | Yield 2006 * |
-
| Yield 2007 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.75% | +1.43% | +7.13% | +83.44% | 45.63B | ||
| -0.20% | -3.59% | +38.01% | +87.26% | 33.53B | ||
| +0.44% | -0.85% | -7.55% | +44.74% | 11.81B | ||
| -0.11% | +1.44% | +12.86% | +116.61% | 11.69B | ||
| +0.59% | +0.78% | +36.70% | +126.43% | 9.12B | ||
| +2.40% | +0.08% | +17.77% | +43.22% | 7.16B | ||
| -1.12% | -0.56% | +40.12% | -18.60% | 6.49B | ||
| +1.37% | +0.35% | +32.58% | +240.43% | 6.45B | ||
| +0.51% | -3.04% | -42.24% | -5.52% | 5.16B | ||
| Average | +0.51% | -0.07% | +15.04% | +79.78% | 15.23B | |
| Weighted average by Cap. | +0.42% | -0.30% | +17.34% | +83.84% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 1.78 1.54 1.42 1.33 2.49 169.29 2.53 16.74 6.53 82.4 6.68 6.54 285.3 | 2.67 2.3 2.12 1.99 3.72 253.5 3.78 25.06 9.77 123.39 10.01 9.8 427.23 |
| Net income | -61.09M -52.76M -48.62M -45.51M -85.29M -5.81B -86.61M -574M -224M -2.83B -229M -224M -9.79B | -53.73M -46.41M -42.76M -40.03M -75.02M -5.11B -76.18M -505M -197M -2.49B -202M -197M -8.61B |
| Net Debt | -52.87M -45.67M -42.08M -39.39M -73.82M -5.03B -74.96M -497M -194M -2.45B -198M -194M -8.47B | -14.76M -12.75M -11.75M -10.99M -20.6M -1.4B -20.92M -139M -54.07M -683M -55.39M -54.21M -2.36B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















